Use of angiotensin II receptor blocker during pregnancy: A case report

BACKGROUND: Drugs that affect the renin-angiotensin system, such as angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors are not typically recommended for pregnant women because of their potential fetal toxicity. CASE STUDY: A 32-year-old pregnant woman with nephrotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Qiang, Zhang, Li, Duan, Mei-fan, Wang, Yue-mei, Huang, Nan, Song, Chun-rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837885/
https://www.ncbi.nlm.nih.gov/pubmed/33546057
http://dx.doi.org/10.1097/MD.0000000000024304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837885/
https://www.ncbi.nlm.nih.gov/pubmed/33546057
http://dx.doi.org/10.1097/MD.0000000000024304

Ejemplares similares